• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM

IMMUTEP LIMITED - Announcements

1.89% ! 27.0¢
Market Cap $396.3M  !

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



IMM Immutep Quarterly Activities Report and Appendix 4CPRICE SENSITIVE30/07/25 download Created with Sketch. 563.42KB
IMM TACTI-004 trial in progress poster to be presented at WCLC29/07/25 download Created with Sketch. 247.77KB
IMM Abstracts Accepted for Presentation at ESMO Congress 202528/07/25 download Created with Sketch. 223.82KB
IMM Ceasing to be a substantial holder25/07/25 download Created with Sketch. 937.69KB
IMM Ceasing to be a substantial holder23/07/25 download Created with Sketch. 236.04KB
IMM Application for quotation of securities - IMM18/07/25 download Created with Sketch. 15.6KB
IMM Application for quotation of securities - IMM18/07/25 download Created with Sketch. 15.6KB
IMM Change in substantial holding17/07/25 download Created with Sketch. 886.5KB
IMM Change in substantial holding30/06/25 download Created with Sketch. 251.25KB
IMM Update on Phase I Study of IMP761 for Autoimmune DiseasesPRICE SENSITIVE23/06/25 download Created with Sketch. 282.33KB
IMM Immutep Corporate Presentation02/06/25 download Created with Sketch. 3.75MB
IMM Primary Endpoint Met in Phase II Soft Tissue Sarcoma TrialPRICE SENSITIVE26/05/25 download Created with Sketch. 204.99KB
IMM High Response Rates achieved in Lung Cancer in INSIGHT-003PRICE SENSITIVE15/05/25 download Created with Sketch. 262.28KB
IMM Excellent Overall Survival in Head & Neck Cancer PatientsPRICE SENSITIVE05/05/25 download Created with Sketch. 274.92KB
IMM Change in substantial holding01/05/25 download Created with Sketch. 98.74KB
IMM Immutep Quarterly Activities Report and Appendix 4CPRICE SENSITIVE29/04/25 download Created with Sketch. 518.27KB
IMM Immutep Investor Update23/04/25 download Created with Sketch. 594.9KB
IMM Change in substantial holding11/04/25 download Created with Sketch. 1.22MB
IMM Change of Director's Interest Notice - M Voigt08/04/25 download Created with Sketch. 127.05KB
IMM Change of Director's Interest Notice F Triebel08/04/25 download Created with Sketch. 128.98KB
IMM Application for quotation of securities - IMM03/04/25 download Created with Sketch. 16.39KB
IMM Immutep to Participate in Upcoming Investor Conferences02/04/25 download Created with Sketch. 174.25KB
IMM First patient dosed in phase 3 TACTI-004 lung cancer trialPRICE SENSITIVE25/03/25 download Created with Sketch. 273.27KB
IMM TACTI-004 trial in progress poster to be presented at ELCC20/03/25 download Created with Sketch. 234.63KB
IMM Half Yearly Report and AccountsPRICE SENSITIVE26/02/25 download Created with Sketch. 888.77KB
IMM Notification of cessation of securities - IMM06/02/25 download Created with Sketch. 12.74KB
IMM Immutep Corporate Presentation05/02/25 download Created with Sketch. 3.37MB
IMM Immutep Quarterly Activities Report and Appendix 4CPRICE SENSITIVE31/01/25 download Created with Sketch. 400.18KB
IMM Enrolment completed for Ph II trial in Soft Tissue Sarcoma22/01/25 download Created with Sketch. 97.18KB
IMM Patient Enrolment Completed for INSIGHT-00306/01/25 download Created with Sketch. 262.36KB
IMM Notification of cessation of securities - IMM17/12/24 download Created with Sketch. 12.73KB
IMM Immutep announces initial safety data from IMP761 phase 1PRICE SENSITIVE17/12/24 download Created with Sketch. 101.88KB
IMM Publication Detailing How Human LAG-3 Binds to MHC Class II16/12/24 download Created with Sketch. 384.45KB
IMM Application for quotation of securities - IMM13/12/24 download Created with Sketch. 15.75KB
IMM Immutep Reports Promising New Data in Head and Neck CancerPRICE SENSITIVE12/12/24 download Created with Sketch. 865.06KB
IMM Change of Director's Interest Notice - L Boyce10/12/24 download Created with Sketch. 125.62KB
IMM Change of Director's Interest Notice - R Howard10/12/24 download Created with Sketch. 126.18KB
IMM Change of Director's Interest Notice - F Triebel10/12/24 download Created with Sketch. 127.82KB
IMM Change of Director's Interest Notice - M Voigt10/12/24 download Created with Sketch. 125.74KB
IMM Initiation of TACTI-004 phase 3 trial in 1st line NSCLCPRICE SENSITIVE10/12/24 download Created with Sketch. 182.79KB
IMM Application for quotation of securities - IMM06/12/24 download Created with Sketch. 16.34KB
IMM Notification regarding unquoted securities - IMM05/12/24 download Created with Sketch. 16.25KB
IMM Immutep Investor Update26/11/24 download Created with Sketch. 1.07MB
IMM Results of Meeting22/11/24 download Created with Sketch. 136.15KB
IMM Immutep AGM 2024 - CEO's Presentation22/11/24 download Created with Sketch. 1.43MB
IMM Immutep AGM 2024 - Chairman's Address22/11/24 download Created with Sketch. 190.03KB
IMM Change in substantial holding18/11/24 download Created with Sketch. 91.09KB
IMM Excellent Survival Data from INSIGHT-003 Trial in NSCLCPRICE SENSITIVE14/11/24 download Created with Sketch. 299.39KB
IMM Positive Data from Phase II Trial in Soft Tissue SarcomaPRICE SENSITIVE14/11/24 download Created with Sketch. 262.09KB
IMM Becoming a substantial holder14/11/24 download Created with Sketch. 606.6KB
IMM Immutep Quarterly Activities Report and Appendix 4CPRICE SENSITIVE29/10/24 download Created with Sketch. 1.02MB
IMM TACTI-003 Cohort B data to be presented at ESMO I-O28/10/24 download Created with Sketch. 179.92KB
IMM Annual Report filed on Form 20-F with SEC23/10/24 download Created with Sketch. 780.19KB
IMM Notice of Annual General Meeting/Proxy Form22/10/24 download Created with Sketch. 1.42MB
IMM Appendix 4G and Corporate Governance Statement22/10/24 download Created with Sketch. 603.94KB
IMM Annual Report to shareholders22/10/24 download Created with Sketch. 1.03MB
IMM Ceasing to be a substantial holder21/10/24 download Created with Sketch. 506.67KB
IMM Change in substantial holding18/10/24 download Created with Sketch. 340.14KB
IMM Becoming a substantial holder17/10/24 download Created with Sketch. 1.95MB
IMM IMP761 Progresses to Dose Escalation Portion of Ph1 Trial17/10/24 download Created with Sketch. 232.21KB
IMM Appendix 3Z - Anne Anderson14/10/24 download Created with Sketch. 107.5KB
IMM 2024 AGM & Key Dates10/10/24 download Created with Sketch. 211.27KB
IMM Resignation of Non-executive Director04/10/24 download Created with Sketch. 161.67KB
IMM Enrolment for Ph II AIPAC-003 Breast Cancer Trial CompletedPRICE SENSITIVE03/10/24 download Created with Sketch. 164.41KB
IMM Change of Director's Interest Notice - Pete Meyers02/10/24 download Created with Sketch. 129.24KB
IMM Application for quotation of securities - IMM01/10/24 download Created with Sketch. 16.32KB
IMM Ceasing to be a substantial holder26/09/24 download Created with Sketch. 563.85KB
IMM Change in substantial holding from IFL25/09/24 download Created with Sketch. 240.34KB
IMM Change in substantial holding24/09/24 download Created with Sketch. 96.51KB
IMM Immutep receives A$3.6 million French R&D Tax IncentivePRICE SENSITIVE24/09/24 download Created with Sketch. 169.64KB
IMM Change of Director's Interest Notice - M Voigt19/09/24 download Created with Sketch. 164.73KB
IMM Data to be presented from Ph II trial in Soft Tissue Sarcoma18/09/24 download Created with Sketch. 195.45KB
IMM New Positive Efficacy Data for Efti in Head and Neck CancerPRICE SENSITIVE16/09/24 download Created with Sketch. 346.6KB
IMM Becoming a substantial holder12/09/24 download Created with Sketch. 2.02MB
IMM S&P DJI Announces September 2024 Quarterly RebalancePRICE SENSITIVE06/09/24 download Created with Sketch. 145.4KB
IMM Appendix 4E & 2024 Full Year Statutory AccountsPRICE SENSITIVE30/08/24 download Created with Sketch. 1.58MB
IMM Immutep Corporate Presentation21/08/24 download Created with Sketch. 4.27MB
IMM TACTI-003 data selected for oral presentation at ESMO 2024PRICE SENSITIVE20/08/24 download Created with Sketch. 247.71KB
IMM First Participant Dosed in Phase I Study of IMP761PRICE SENSITIVE14/08/24 download Created with Sketch. 253.4KB
IMM Immutep to Participate in Upcoming Investor Conferences07/08/24 download Created with Sketch. 163.45KB
IMM Immutep Quarterly Activities Report and Appendix 4CPRICE SENSITIVE31/07/24 download Created with Sketch. 597.53KB
IMM Change in substantial holding26/07/24 download Created with Sketch. 623.25KB
IMM Successful Meeting with FDA on Phase III Design in NSCLCPRICE SENSITIVE22/07/24 download Created with Sketch. 240.17KB
IMM Regulatory Clearance received for Phase 1 trial of IMP761PRICE SENSITIVE17/07/24 download Created with Sketch. 266.83KB
IMM Becoming a substantial holder12/07/24 download Created with Sketch. 256.59KB
IMM Positive results in TACTI-003 for 1L HNSCC cohort B patientsPRICE SENSITIVE12/07/24 download Created with Sketch. 247KB
IMM Webcast to discuss data presented at ESMO Plenary SessionPRICE SENSITIVE12/07/24 download Created with Sketch. 934.44KB
IMM Change in substantial holding04/07/24 download Created with Sketch. 459.85KB
IMM Details for Immutep Webcast & ESMO Virtual Plenary Session03/07/24 download Created with Sketch. 242.98KB
IMM Webcast slides for new Efti clinical data in 1st line HNSCCPRICE SENSITIVE27/06/24 download Created with Sketch. 1.99MB
IMM Positive topline results from ph2b in head & neck cancerPRICE SENSITIVE27/06/24 download Created with Sketch. 289.08KB
IMM Application for quotation of securities - IMM25/06/24 download Created with Sketch. 14.24KB
IMM Immutep signs agreement for anti-LAG-3 small molecules25/06/24 download Created with Sketch. 181.5KB
IMM Immutep completes underwritten retail entitlement offerPRICE SENSITIVE24/06/24 download Created with Sketch. 186.65KB
IMM Change in substantial holding from IFL18/06/24 download Created with Sketch. 215.88KB
IMM Change in substantial holding14/06/24 download Created with Sketch. 624.55KB
IMM Change in substantial holding14/06/24 download Created with Sketch. 472KB
IMM Cleansing Notice12/06/24 download Created with Sketch. 208.57KB
IMM Application for quotation of securities - IMM12/06/24 download Created with Sketch. 17.8KB
IMM Immutep letter to ineligible shareholders07/06/24 download Created with Sketch. 238.33KB
IMM Immutep Quarterly Activities Report and Appendix 4C
30/07/25PRICE SENSITIVE download Created with Sketch. 563.42KB
IMM TACTI-004 trial in progress poster to be presented at WCLC
29/07/25 download Created with Sketch. 247.77KB
IMM Abstracts Accepted for Presentation at ESMO Congress 2025
28/07/25 download Created with Sketch. 223.82KB
IMM Ceasing to be a substantial holder
25/07/25 download Created with Sketch. 937.69KB
IMM Ceasing to be a substantial holder
23/07/25 download Created with Sketch. 236.04KB
IMM Application for quotation of securities - IMM
18/07/25 download Created with Sketch. 15.6KB
IMM Application for quotation of securities - IMM
18/07/25 download Created with Sketch. 15.6KB
IMM Change in substantial holding
17/07/25 download Created with Sketch. 886.5KB
IMM Change in substantial holding
30/06/25 download Created with Sketch. 251.25KB
IMM Update on Phase I Study of IMP761 for Autoimmune Diseases
23/06/25PRICE SENSITIVE download Created with Sketch. 282.33KB
IMM Immutep Corporate Presentation
02/06/25 download Created with Sketch. 3.75MB
IMM Primary Endpoint Met in Phase II Soft Tissue Sarcoma Trial
26/05/25PRICE SENSITIVE download Created with Sketch. 204.99KB
IMM High Response Rates achieved in Lung Cancer in INSIGHT-003
15/05/25PRICE SENSITIVE download Created with Sketch. 262.28KB
IMM Excellent Overall Survival in Head & Neck Cancer Patients
05/05/25PRICE SENSITIVE download Created with Sketch. 274.92KB
IMM Change in substantial holding
01/05/25 download Created with Sketch. 98.74KB
IMM Immutep Quarterly Activities Report and Appendix 4C
29/04/25PRICE SENSITIVE download Created with Sketch. 518.27KB
IMM Immutep Investor Update
23/04/25 download Created with Sketch. 594.9KB
IMM Change in substantial holding
11/04/25 download Created with Sketch. 1.22MB
IMM Change of Director's Interest Notice - M Voigt
08/04/25 download Created with Sketch. 127.05KB
IMM Change of Director's Interest Notice F Triebel
08/04/25 download Created with Sketch. 128.98KB
IMM Application for quotation of securities - IMM
03/04/25 download Created with Sketch. 16.39KB
IMM Immutep to Participate in Upcoming Investor Conferences
02/04/25 download Created with Sketch. 174.25KB
IMM First patient dosed in phase 3 TACTI-004 lung cancer trial
25/03/25PRICE SENSITIVE download Created with Sketch. 273.27KB
IMM TACTI-004 trial in progress poster to be presented at ELCC
20/03/25 download Created with Sketch. 234.63KB
IMM Half Yearly Report and Accounts
26/02/25PRICE SENSITIVE download Created with Sketch. 888.77KB
IMM Notification of cessation of securities - IMM
06/02/25 download Created with Sketch. 12.74KB
IMM Immutep Corporate Presentation
05/02/25 download Created with Sketch. 3.37MB
IMM Immutep Quarterly Activities Report and Appendix 4C
31/01/25PRICE SENSITIVE download Created with Sketch. 400.18KB
IMM Enrolment completed for Ph II trial in Soft Tissue Sarcoma
22/01/25 download Created with Sketch. 97.18KB
IMM Patient Enrolment Completed for INSIGHT-003
06/01/25 download Created with Sketch. 262.36KB
IMM Notification of cessation of securities - IMM
17/12/24 download Created with Sketch. 12.73KB
IMM Immutep announces initial safety data from IMP761 phase 1
17/12/24PRICE SENSITIVE download Created with Sketch. 101.88KB
IMM Publication Detailing How Human LAG-3 Binds to MHC Class II
16/12/24 download Created with Sketch. 384.45KB
IMM Application for quotation of securities - IMM
13/12/24 download Created with Sketch. 15.75KB
IMM Immutep Reports Promising New Data in Head and Neck Cancer
12/12/24PRICE SENSITIVE download Created with Sketch. 865.06KB
IMM Change of Director's Interest Notice - L Boyce
10/12/24 download Created with Sketch. 125.62KB
IMM Change of Director's Interest Notice - R Howard
10/12/24 download Created with Sketch. 126.18KB
IMM Change of Director's Interest Notice - F Triebel
10/12/24 download Created with Sketch. 127.82KB
IMM Change of Director's Interest Notice - M Voigt
10/12/24 download Created with Sketch. 125.74KB
IMM Initiation of TACTI-004 phase 3 trial in 1st line NSCLC
10/12/24PRICE SENSITIVE download Created with Sketch. 182.79KB
IMM Application for quotation of securities - IMM
06/12/24 download Created with Sketch. 16.34KB
IMM Notification regarding unquoted securities - IMM
05/12/24 download Created with Sketch. 16.25KB
IMM Immutep Investor Update
26/11/24 download Created with Sketch. 1.07MB
IMM Results of Meeting
22/11/24 download Created with Sketch. 136.15KB
IMM Immutep AGM 2024 - CEO's Presentation
22/11/24 download Created with Sketch. 1.43MB
IMM Immutep AGM 2024 - Chairman's Address
22/11/24 download Created with Sketch. 190.03KB
IMM Change in substantial holding
18/11/24 download Created with Sketch. 91.09KB
IMM Excellent Survival Data from INSIGHT-003 Trial in NSCLC
14/11/24PRICE SENSITIVE download Created with Sketch. 299.39KB
IMM Positive Data from Phase II Trial in Soft Tissue Sarcoma
14/11/24PRICE SENSITIVE download Created with Sketch. 262.09KB
IMM Becoming a substantial holder
14/11/24 download Created with Sketch. 606.6KB
IMM Immutep Quarterly Activities Report and Appendix 4C
29/10/24PRICE SENSITIVE download Created with Sketch. 1.02MB
IMM TACTI-003 Cohort B data to be presented at ESMO I-O
28/10/24 download Created with Sketch. 179.92KB
IMM Annual Report filed on Form 20-F with SEC
23/10/24 download Created with Sketch. 780.19KB
IMM Notice of Annual General Meeting/Proxy Form
22/10/24 download Created with Sketch. 1.42MB
IMM Appendix 4G and Corporate Governance Statement
22/10/24 download Created with Sketch. 603.94KB
IMM Annual Report to shareholders
22/10/24 download Created with Sketch. 1.03MB
IMM Ceasing to be a substantial holder
21/10/24 download Created with Sketch. 506.67KB
IMM Change in substantial holding
18/10/24 download Created with Sketch. 340.14KB
IMM Becoming a substantial holder
17/10/24 download Created with Sketch. 1.95MB
IMM IMP761 Progresses to Dose Escalation Portion of Ph1 Trial
17/10/24 download Created with Sketch. 232.21KB
IMM Appendix 3Z - Anne Anderson
14/10/24 download Created with Sketch. 107.5KB
IMM 2024 AGM & Key Dates
10/10/24 download Created with Sketch. 211.27KB
IMM Resignation of Non-executive Director
04/10/24 download Created with Sketch. 161.67KB
IMM Enrolment for Ph II AIPAC-003 Breast Cancer Trial Completed
03/10/24PRICE SENSITIVE download Created with Sketch. 164.41KB
IMM Change of Director's Interest Notice - Pete Meyers
02/10/24 download Created with Sketch. 129.24KB
IMM Application for quotation of securities - IMM
01/10/24 download Created with Sketch. 16.32KB
IMM Ceasing to be a substantial holder
26/09/24 download Created with Sketch. 563.85KB
IMM Change in substantial holding from IFL
25/09/24 download Created with Sketch. 240.34KB
IMM Change in substantial holding
24/09/24 download Created with Sketch. 96.51KB
IMM Immutep receives A$3.6 million French R&D Tax Incentive
24/09/24PRICE SENSITIVE download Created with Sketch. 169.64KB
IMM Change of Director's Interest Notice - M Voigt
19/09/24 download Created with Sketch. 164.73KB
IMM Data to be presented from Ph II trial in Soft Tissue Sarcoma
18/09/24 download Created with Sketch. 195.45KB
IMM New Positive Efficacy Data for Efti in Head and Neck Cancer
16/09/24PRICE SENSITIVE download Created with Sketch. 346.6KB
IMM Becoming a substantial holder
12/09/24 download Created with Sketch. 2.02MB
IMM S&P DJI Announces September 2024 Quarterly Rebalance
06/09/24PRICE SENSITIVE download Created with Sketch. 145.4KB
IMM Appendix 4E & 2024 Full Year Statutory Accounts
30/08/24PRICE SENSITIVE download Created with Sketch. 1.58MB
IMM Immutep Corporate Presentation
21/08/24 download Created with Sketch. 4.27MB
IMM TACTI-003 data selected for oral presentation at ESMO 2024
20/08/24PRICE SENSITIVE download Created with Sketch. 247.71KB
IMM First Participant Dosed in Phase I Study of IMP761
14/08/24PRICE SENSITIVE download Created with Sketch. 253.4KB
IMM Immutep to Participate in Upcoming Investor Conferences
07/08/24 download Created with Sketch. 163.45KB
IMM Immutep Quarterly Activities Report and Appendix 4C
31/07/24PRICE SENSITIVE download Created with Sketch. 597.53KB
IMM Change in substantial holding
26/07/24 download Created with Sketch. 623.25KB
IMM Successful Meeting with FDA on Phase III Design in NSCLC
22/07/24PRICE SENSITIVE download Created with Sketch. 240.17KB
IMM Regulatory Clearance received for Phase 1 trial of IMP761
17/07/24PRICE SENSITIVE download Created with Sketch. 266.83KB
IMM Becoming a substantial holder
12/07/24 download Created with Sketch. 256.59KB
IMM Positive results in TACTI-003 for 1L HNSCC cohort B patients
12/07/24PRICE SENSITIVE download Created with Sketch. 247KB
IMM Webcast to discuss data presented at ESMO Plenary Session
12/07/24PRICE SENSITIVE download Created with Sketch. 934.44KB
IMM Change in substantial holding
04/07/24 download Created with Sketch. 459.85KB
IMM Details for Immutep Webcast & ESMO Virtual Plenary Session
03/07/24 download Created with Sketch. 242.98KB
IMM Webcast slides for new Efti clinical data in 1st line HNSCC
27/06/24PRICE SENSITIVE download Created with Sketch. 1.99MB
IMM Positive topline results from ph2b in head & neck cancer
27/06/24PRICE SENSITIVE download Created with Sketch. 289.08KB
IMM Application for quotation of securities - IMM
25/06/24 download Created with Sketch. 14.24KB
IMM Immutep signs agreement for anti-LAG-3 small molecules
25/06/24 download Created with Sketch. 181.5KB
IMM Immutep completes underwritten retail entitlement offer
24/06/24PRICE SENSITIVE download Created with Sketch. 186.65KB
IMM Change in substantial holding from IFL
18/06/24 download Created with Sketch. 215.88KB
IMM Change in substantial holding
14/06/24 download Created with Sketch. 624.55KB
IMM Change in substantial holding
14/06/24 download Created with Sketch. 472KB
IMM Cleansing Notice
12/06/24 download Created with Sketch. 208.57KB
IMM Application for quotation of securities - IMM
12/06/24 download Created with Sketch. 17.8KB
IMM Immutep letter to ineligible shareholders
07/06/24 download Created with Sketch. 238.33KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
27.0¢
Change
0.005(1.89%)
Mkt cap ! $396.3M
Open High Low Value Volume
26.5¢ 27.0¢ 26.5¢ $185.3K 690.4K

Buyers (Bids)

No. Vol. Price($)
3 92193 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 134673 7
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
Last
27.0¢
  Change
0.005 ( 0.00 %)
Open High Low Volume
26.8¢ 27.0¢ 26.5¢ 586726
Last updated 15.59pm 31/07/2025 ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.